126 related articles for article (PubMed ID: 36191672)
21. Mechanism of cellular uptake and cytotoxicity of paclitaxel loaded lipid nanocapsules in breast cancer cells.
Valsalakumari R; Yadava SK; Szwed M; Pandya AD; Mælandsmo GM; Torgersen ML; Iversen TG; Skotland T; Sandvig K; Giri J
Int J Pharm; 2021 Mar; 597():120217. PubMed ID: 33486035
[TBL] [Abstract][Full Text] [Related]
22. Co-encapsulation of docetaxel and thymoquinone in mPEG-DSPE-vitamin E TPGS-lipid nanocapsules for breast cancer therapy: Formulation optimization and implications on cellular and in vivo toxicity.
Zafar S; Akhter S; Garg N; Selvapandiyan A; Kumar Jain G; Ahmad FJ
Eur J Pharm Biopharm; 2020 Mar; 148():10-26. PubMed ID: 31923585
[TBL] [Abstract][Full Text] [Related]
23. Switching indication of PEGylated lipid nanocapsules-loaded with rolapitant and deferasirox against breast cancer: Enhanced in-vitro and in-vivo cytotoxicity.
Kabil MF; Mahmoud MY; Bakr AF; Zaafar D; El-Sherbiny IM
Life Sci; 2022 Sep; 305():120731. PubMed ID: 35753435
[TBL] [Abstract][Full Text] [Related]
24. Lipid nanocarriers improve paclitaxel transport throughout human intestinal epithelial cells by using vesicle-mediated transcytosis.
Roger E; Lagarce F; Garcion E; Benoit JP
J Control Release; 2009 Dec; 140(2):174-81. PubMed ID: 19699246
[TBL] [Abstract][Full Text] [Related]
25. Baicalin lipid nanocapsules for treatment of glioma: characterization, mechanistic cytotoxicity, and pharmacokinetic evaluation.
Ibrahim A; Abdel Gaber SA; Fawzi Kabil M; Ahmed-Farid OAH; Hirsch AKH; El-Sherbiny IM; Nasr M
Expert Opin Drug Deliv; 2022 Nov; 19(11):1549-1560. PubMed ID: 36287914
[TBL] [Abstract][Full Text] [Related]
26. Influence of size, surface coating and fine chemical composition on the in vitro reactivity and in vivo biodistribution of lipid nanocapsules versus lipid nanoemulsions in cancer models.
Hirsjärvi S; Dufort S; Gravier J; Texier I; Yan Q; Bibette J; Sancey L; Josserand V; Passirani C; Benoit JP; Coll JL
Nanomedicine; 2013 Apr; 9(3):375-87. PubMed ID: 22960195
[TBL] [Abstract][Full Text] [Related]
27. Distribution of lipid nanocapsules in different cochlear cell populations after round window membrane permeation.
Zou J; Saulnier P; Perrier T; Zhang Y; Manninen T; Toppila E; Pyykkö I
J Biomed Mater Res B Appl Biomater; 2008 Oct; 87(1):10-8. PubMed ID: 18437698
[TBL] [Abstract][Full Text] [Related]
28. Galactosylated DNA lipid nanocapsules for efficient hepatocyte targeting.
Morille M; Passirani C; Letrou-Bonneval E; Benoit JP; Pitard B
Int J Pharm; 2009 Sep; 379(2):293-300. PubMed ID: 19505548
[TBL] [Abstract][Full Text] [Related]
29. An
Radwan Y; Arafa KK; Ghoniem MG; Al-Farraj ES; El-Sherbiny IM
Drug Dev Ind Pharm; 2023 Mar; 49(3):271-280. PubMed ID: 37067846
[TBL] [Abstract][Full Text] [Related]
30. Targeting of immunosuppressive myeloid cells from glioblastoma patients by modulation of size and surface charge of lipid nanocapsules.
Pinton L; Magri S; Masetto E; Vettore M; Schibuola I; Ingangi V; Marigo I; Matha K; Benoit JP; Della Puppa A; Bronte V; Lollo G; Mandruzzato S
J Nanobiotechnology; 2020 Feb; 18(1):31. PubMed ID: 32066449
[TBL] [Abstract][Full Text] [Related]
31. Preparation and characterization of tetrandrine-phospholipid complex loaded lipid nanocapsules as potential oral carriers.
Zhao YQ; Wang LP; Ma C; Zhao K; Liu Y; Feng NP
Int J Nanomedicine; 2013; 8():4169-81. PubMed ID: 24204145
[TBL] [Abstract][Full Text] [Related]
32. Administration-dependent efficacy of ferrociphenol lipid nanocapsules for the treatment of intracranial 9L rat gliosarcoma.
Huynh NT; Passirani C; Allard-Vannier E; Lemaire L; Roux J; Garcion E; Vessieres A; Benoit JP
Int J Pharm; 2012 Feb; 423(1):55-62. PubMed ID: 21536115
[TBL] [Abstract][Full Text] [Related]
33. Efavirenz oral delivery via lipid nanocapsules: formulation, optimisation, and ex-vivo gut permeation study.
Varshosaz J; Taymouri S; Jahanian-Najafabadi A; Alizadeh A
IET Nanobiotechnol; 2018 Sep; 12(6):795-806. PubMed ID: 30104454
[TBL] [Abstract][Full Text] [Related]
34. Surface active properties of lipid nanocapsules.
Mouzouvi CRA; Umerska A; Bigot AK; Saulnier P
PLoS One; 2017; 12(8):e0179211. PubMed ID: 28796777
[TBL] [Abstract][Full Text] [Related]
35. Understanding the Thermodynamic Mechanisms Leading to the Binding of Albumin to Lipid Nanocapsules.
Umerska A; Sapin-Minet A; Parent M; Tajber L; Maincent P; Boudier A
Langmuir; 2020 Apr; 36(15):4165-4173. PubMed ID: 32223171
[TBL] [Abstract][Full Text] [Related]
36. Absence of lung fibrosis after a single pulmonary delivery of lipid nanocapsules in rats.
Hureaux J; Lacoeuille F; Lagarce F; Rousselet MC; Contini A; Saulnier P; Benoit JP; Urban T
Int J Nanomedicine; 2017; 12():8159-8170. PubMed ID: 29184405
[TBL] [Abstract][Full Text] [Related]
37. Lipid nanocapsules for transdermal delivery of ropivacaine: in vitro and in vivo evaluation.
Zhai Y; Yang X; Zhao L; Wang Z; Zhai G
Int J Pharm; 2014 Aug; 471(1-2):103-11. PubMed ID: 24858383
[TBL] [Abstract][Full Text] [Related]
38. Miltefosine Lipid Nanocapsules for Single Dose Oral Treatment of Schistosomiasis Mansoni: A Preclinical Study.
Eissa MM; El-Moslemany RM; Ramadan AA; Amer EI; El-Azzouni MZ; El-Khordagui LK
PLoS One; 2015; 10(11):e0141788. PubMed ID: 26574746
[TBL] [Abstract][Full Text] [Related]
39. In vivo imaging of DNA lipid nanocapsules after systemic administration in a melanoma mouse model.
David S; Carmoy N; Resnier P; Denis C; Misery L; Pitard B; Benoit JP; Passirani C; Montier T
Int J Pharm; 2012 Feb; 423(1):108-15. PubMed ID: 21726617
[TBL] [Abstract][Full Text] [Related]
40. Lipid nanocapsules co-encapsulating paclitaxel and salinomycin for eradicating breast cancer and cancer stem cells.
Basu SM; Yadava SK; Singh R; Giri J
Colloids Surf B Biointerfaces; 2021 Aug; 204():111775. PubMed ID: 33940518
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
